Korea South
ROWAN Inc is a pioneering company in the field of digital therapeutics for dementia. Using big data and artificial intelligence, ROWAN leads innovation in the cognitive mediation digital therapeutic environment. The company plans, develops, and delivers personalized dementia prevention content by collecting and analyzing patient brain cognitive function information.
To address the increasing need and interest in preventing dementia, particularly with the growing elderly population reaching 8 million in 2021, ROWAN Inc aims to establish a future-oriented business model. This involves fostering collaborations with institutions requiring researcher data management, such as medical institutions and life insurance companies, to meet this societal challenge.
In line with Rowan's organizational culture philosophy, “Optimize Surroundings,” the company envisions taking the lead in preparing for the upcoming ultra-aging society by evolving as a brain disease digital treatment company.
Founded in 2017 and headquartered in Korea South, ROWAN Inc. received a significant KRW6.00B Series A investment on 07 February 2022. The investment was made by Industrial Bank of Korea, NauIB, KD investment, Dt& Investment.
This recent investment not only highlights the potential of ROWAN Inc. but also signifies the growing interest in digital therapeutics and dementia prevention. With its innovative approach and strong backing, ROWAN Inc. is poised to lead the way in addressing the complex challenges of cognitive mediation and brain disease treatment.
